Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.75M Buy
10,324
+60
+0.6% +$16.6K 0.03% 321
2025
Q4
$2.84M Buy
10,264
+282
+3% +$79.1K 0.04% 295
2025
Q3
$2.88M Sell
9,982
-789
-7% -$233K 0.04% 293
2025
Q2
$3.56M Buy
10,771
+602
+6% +$194K 0.05% 244
2025
Q1
$3.35M Sell
10,169
-1,001
-9% -$302K 0.05% 241
2024
Q4
$3.08M Sell
11,170
-1,071
-9% -$341K 0.04% 257
2024
Q3
$4.26M Buy
12,241
+1,435
+13% +$494K 0.06% 212
2024
Q2
$3.53M Buy
10,806
+9,183
+566% +$3.17M 0.06% 213
2024
Q1
$590K Buy
1,623
+573
+55% +$189K 0.02% 400
2023
Q4
$314K Buy
+1,050
New +$307K 0.01% 484

Other funds holding CI

Choreo LLC's CI Position: Q1 2026 in Review

Choreo LLC increased its Cigna (CI) stake by 0.58% in Q1 2026, buying an estimated $16.6K and bringing the position to 10,324 shares worth $2.75M. The position accounts for 0.03% of the portfolio, ranked #321.

Choreo LLC first reported a position in CI in Q4 2023 and has held it in 10 quarters since. The position peaked at $4.26M in Q3 2024. 1,655 funds tracked by Wall St. Rank hold CI as of Q1 2026.

  • Choreo LLC held 10,324 shares of Cigna worth $2.75M as of Q1 2026.
  • Choreo LLC bought 60 Cigna shares in Q1 2026, an estimated $16.6K.
  • Cigna made up 0.03% of Choreo LLC's portfolio in Q1 2026, its #321 holding.
  • Choreo LLC first reported a position in Cigna in Q4 2023 and has held it in 10 quarters since.
  • Choreo LLC's Cigna position peaked at $4.26M in Q3 2024.
  • 1,655 funds tracked by Wall St. Rank held Cigna as of Q1 2026.

Based on Choreo LLC's 13F filing for Q1 2026, filed 13 May 2026.